The morphological changes during EMT are driven by a number of molecular and cellular alterations, including loss or decrease of epithelial cell markers (e.g., E-cadherin, ??-catenin, ??-catenin, p120-catenin) and de novo expression of mesenchymal markers (e.g., N-cadherin, vimentin, fibronectin).